AKAP8L, short for A-Kinase Anchoring Protein 8-Like, plays a significant role in cellular signaling by anchoring Protein Kinase A (PKA) to specific subcellular compartments. This precise localization is crucial for the spatial and temporal regulation of PKA phosphorylation events within the cell. AKAP8L is particularly interesting because it has been associated with the regulation of chromatin structure and gene transcription, suggesting that it serves as a bridge between PKA signaling and the modulation of gene expression. The expression of AKAP8L itself is subject to cellular control mechanisms and can be influenced by various intracellular signaling pathways and external stimuli. Understanding the regulatory network surrounding AKAP8L expression provides insights into the broader context of cellular homeostasis and the intricate balance of signaling pathways.
Certain chemical compounds have been identified that could stimulate the expression of AKAP8L through diverse mechanisms of action. For example, compounds like Forskolin, which increases intracellular cAMP levels, could induce AKAP8L by enhancing the activity of PKA and subsequent phosphorylation of transcription factors that activate gene expression. Histone deacetylase inhibitors such as Trichostatin A and Sodium butyrate are known to alter the chromatin landscape, leading to increased transcription of a variety of genes, including AKAP8L. DNA methyltransferase inhibitors like 5-Azacytidine could also upregulate AKAP8L by promoting the demethylation and reactivation of epigenetically silenced gene promoters. Moreover, natural polyphenols such as Epigallocatechin gallate, Sulforaphane, Curcumin, and Resveratrol are thought to interact with cellular signaling cascades, which may result in the enhanced transcription of genes that respond to these signaling pathways. Lastly, small molecule inhibitors like Lithium chloride and Metformin could influence gene expression through the inhibition of GSK-3 and activation of AMPK, respectively, suggesting that they might play a role in the upregulation of genes like AKAP8L. It is important to note that while these compounds have known biological activities that could lead to the induction of AKAP8L, specific outcomes would depend on the cellular context, and experimental studies would be required to determine their actual effects on AKAP8L expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By activating adenylyl cyclase, Forskolin elevates intracellular cAMP levels, which could enhance protein kinase A (PKA) activity and thereby potentially upregulate transcription of PKA-responsive genes, including AKAP8L. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This cytidine analog interferes with DNA methylation, which can lead to the reactivation of genes that were epigenetically silenced, potentially prompting an increase in AKAP8L expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate may initiate a cascade of phosphorylation events through its antioxidant properties, potentially upregulating transcription factors that can stimulate AKAP8L gene transcription. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane can activate the Nrf2 pathway, leading to the transcriptional activation of antioxidant response element (ARE)-driven genes, which might include the upregulation of AKAP8L in response to oxidative stress. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By activating sirtuin 1 (SIRT1), Resveratrol could promote deacetylation of certain transcription factors or co-regulators, leading to the transcriptional activation of their target genes, which may encompass AKAP8L. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone binds to the glucocorticoid receptor, which can translocate to the nucleus and act as a transcription factor for glucocorticoid-response elements, potentially leading to the upregulation of AKAP8L expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, can cause hyperacetylation of histones, thereby promoting transcriptional activation of various genes, which may include the gene encoding AKAP8L. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which could lead to the stabilization and activation of β-catenin, a transcriptional co-activator that may upregulate Wnt target genes, potentially including AKAP8L. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin activates AMP-activated protein kinase (AMPK), which may trigger a cellular energy-conservation response including the transcriptional activation of genes involved in energy metabolism, potentially leading to an increase in AKAP8L expression. | ||||||